Dyadic (AMEX:DIL)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Dyadic Charts. Click Here for more Dyadic Charts.](/p.php?pid=staticchart&s=A%5EDIL&p=8&t=15)
Dyadic International, Inc. (AMEX: DIL), a biotechnology
company, announced today that Mark Emalfarb, CEO and Glenn Nedwin,
Ph.D., Chief Scientific Officer and President of Dyadic's Biosciences
Business, will make the following presentations to the financial
community:
-- on Tuesday, April 11, 2006 at approximately 1:15 p.m. EDT in
Chicago and
-- on Tuesday, April 18, 2006 at approximately 7:45 a.m. EDT in
New York.
Mr. Emalfarb and Dr. Nedwin will review Dyadic's C1 Host
Technology development program, the company's cellulosic ethanol
opportunity, as well as its progress in industrial enzymes and the
advancement of C1 Expression Technology for use in the development and
production of antibodies and other therapeutic proteins. Both
presentations will be webcast live and can be accessed at
http://www.dyadic-group.com. An archive of the webcasts will be
available for approximately 30 days.
Prior to joining Dyadic in March 2006, Dr. Nedwin was co-founder
and President of Novozymes, Inc., a research & development subsidiary
of Novozymes A/S, Denmark (Copenhagen Stock Exchange: NZYMb.CO).
About Dyadic
Dyadic International, Inc. is engaged in the development,
manufacture and sale of biological products using a number of
proprietary fungal strains to produce enzymes and other biomaterials,
principally focused on a system for protein production based on the
patented Chrysosporium lucknowense fungus, known as C1. Dyadic
currently sells more than 45 liquid and dry enzyme products to more
than 200 industrial customers in approximately 50 countries.
Dyadic intends to utilize its patented enabling and proprietary
platform technologies on its own behalf and under license to business
collaborators for the discovery, development and manufacture of
biological products from genes to produce targeted protein products
for diverse markets.
Cautionary Statement for Forward-Looking Statements
Certain statements contained in this press release are
"forward-looking statements." These forward-looking statements involve
risks and uncertainties that could cause our actual results,
performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. For a discussion of these risks and
uncertainties, please see our filings from time to time with the
Securities and Exchange Commission, which are available free of charge
on the SEC's web site at http://www.sec.gov, including our Annual
Report on Form 10-KSB for the year ended December 31, 2005. Except as
required by law, we expressly disclaim any intent or obligation to
update any forward-looking statements.